(Q37698249)

English

An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease

scientific article published on March 2014

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease (English)

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

sickle-cell disease

0 references

arterial hypertension

0 references

0 references

pulmonary hypertension

1 reference

based on heuristic

inferred from title

Mark T. Gladwin

20

object named as

Mark T Gladwin

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

object named as

Lewis Hsu

13

0 references

Gregory J. Kato

object named as

Gregory J Kato

7

0 references

Erika Berman-Rosenzweig

object named as

Erika B Rosenzweig

11

0 references

Martin H Steinberg

object named as

Martin H Steinberg

18

0 references

author name string

Elizabeth S Klings

1

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Roberto F Machado

2

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Robyn J Barst

3

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Claudia R Morris

4

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Kamal K Mubarak

5

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Victor R Gordeuk

6

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Kenneth I Ataga

8

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

J Simon Gibbs

9

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Oswaldo Castro

10

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Namita Sood

12

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Kevin C Wilson

14

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Marilyn J Telen

15

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Laura M Decastro

16

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Lakshmanan Krishnamurti

17

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

David B Badesch

19

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

American Thoracic Society Ad Hoc Committee on Pulmonary Hypertension of Sickle Cell Disease

21

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

language of work or name

0 references

publication date

1 March 2014

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

American Journal of Respiratory and Critical Care Medicine

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

189

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

727-740

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Hemodynamic predictors of mortality in adults with sickle cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Mortality in adults with sickle cell disease and pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

NT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Elevated tricuspid regurgitation velocity and decline in exercise capacity over 22 months of follow up in children and adolescents with sickle cell anemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Pulmonary arterial hypertension complicating connective tissue diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Endothelin receptor antagonists for pulmonary arterial hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Improvement in hemolysis and pulmonary arterial systolic pressure in adult patients with sickle cell disease during treatment with hydroxyurea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American Coll

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Pulmonary hypertension in COPD: a review and consideration of the role of arterial vasodilators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Pulmonary hypertension: an increasingly recognized complication of hereditary hemolytic anemias and HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Pulmonary diseases and the heart

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Pulmonary hypertension in idiopathic pulmonary fibrosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Pulmonary hypertension in sickle cell disease: relevance to children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

D-dimer testing to determine the duration of anticoagulation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Hydroxyurea and sickle cell anemia: effect on quality of life

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

New strategies for the treatment of pulmonary hypertension in sickle cell disease : the rationale for arginine therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Prostacyclin for pulmonary hypertension in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Phosphodiesterase 5 inhibitors for pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Pulmonary hypertension in chronic obstructive pulmonary disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Blood transfusion for preventing stroke in people with sickle cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Pulmonary complications of sickle cell anemia. A need for increased recognition, treatment, and research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Causes of death in sickle-cell disease in Jamaica

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 August 2017

Misclassification of pulmonary hypertension in adults with sickle hemoglobinopathies using Doppler echocardiography

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

6 September 2017

Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

6 September 2017

Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

6 September 2017

Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

14 September 2017

Longitudinal follow up of elevated pulmonary artery pressures in children with sickle cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 June 2018

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 June 2018

Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 June 2018

Scintigraphic evidence of pulmonary vascular occlusion in sickle cell disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 June 2018

The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 June 2018

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

23 June 2018

A hemodynamic study of pulmonary hypertension in sickle cell disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

1 September 2018

Exposure to hydroxyurea and pregnancy outcomes in patients with sickle cell anemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

1 September 2018

Pulmonary arterial hypertension and left-sided heart disease in sickle cell disease: clinical characteristics and association with soluble adhesion molecule expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

1 September 2018

Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

1 September 2018

Pulmonary hypertension in patients with sickle cell/beta thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

1 September 2018

Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

1 September 2018

N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

1 September 2018

Pulmonary hypertension in patients with sickle cell disease: a longitudinal study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

1 September 2018

Regular transfusion lowers plasma free hemoglobin in children with sickle-cell disease at risk for stroke.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

1 September 2018

Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

1 September 2018

Effect of long-term transfusion on growth in children with sickle cell anemia: results of the STOP trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

1 September 2018

Pulmonary hypertension as a risk factor for death in patients with sickle cell disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

1 September 2018

Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

1 September 2018

Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

1 September 2018

Updated Clinical Classification of Pulmonary Hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983842

1 September 2018

Pulmonary hypertension associated with sickle cell disease: Clinical and laboratory endpoints and disease outcomes

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201401-0065ST

21 January 2018

Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24628312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24628312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

No association of the hypercoagulable state with sickle cell disease related pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/24628312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Portopulmonary Hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/24628312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary complications of sickle cell disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24628312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24628312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/24628312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24628312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP)

1 reference

https://pubmed.ncbi.nlm.nih.gov/24628312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1164/RCCM.201401-0065ST

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37698249&oldid=1723523272"